Cormorant Private Healthcare Fund II, LP's Net Worth
$0
Who is Cormorant Private Healthcare Fund II, LP?
Cormorant Private Healthcare Fund II, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Design Therapeutics, Inc., Atea Pharmaceuticals, Inc., Erasca, Inc., Monte Rosa Therapeutics, Inc., Aerovate Therapeutics, Inc., Avidity Biosciences, Inc., BioAtla, Inc., Rain Therapeutics Inc., Akouos, Inc., Olema Pharmaceuticals, Inc., GreenLight Biosciences Holdings, PBC, and MoonLake Immunotherapeutics.
SEC CIK
Cormorant Private Healthcare Fund II, LP's CIK is 0001747677
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Design Therapeutics, Inc. (DSGN) Snapshot price: $4.67
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.11M |
$20.00 |
—
| 5.11M |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $3.47
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 6.41M |
—
|
—
| 6.41M |
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Erasca, Inc. (ERAS) Snapshot price: $2.86
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4/A
| +2.93% | 307.69K |
$6.50 | $1,999,998.00 | 10.81M |
Dec 13
| |||
Form 4
| +2.93% | 307.69K |
$6.50 | $1,999,998.00 | 10.81M |
Dec 13
| |||
Form 4
|
∞
| 10.51M |
$16.00 |
—
| 10.51M |
Jul 20
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.2M |
$19.00 |
—
| 3.2M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.03M |
$14.00 |
—
| 2.03M |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||